Quadrivalent Human Papillomavirus Vaccine Effectiveness after 12 Years in Madrid (Spain)

Quadrivalent Human Papillomavirus Vaccine Effectiveness after 12 Years in Madrid (Spain)

A fully government-funded human papillomavirus (HPV) vaccination program started in 2007 in Spain (only 11–14-year-old girls). The first of those vaccinated cohorts, with the quadrivalent vaccine (Gardasil), turned 25 years old in 2018, the age at which cervical cancer screening begins in Spain. The...

Full description

Bibliographic Details
Main Authors: Juan J. Hernandez-Aguado, Damián Ángel Sánchez Torres, Esther Martínez Lamela, Gema Aguión Gálvez, Eva Sanz Espinosa, Almudena Pérez Quintanilla, Daniela A. Martínez-Carrillo, Mar Ramírez Mena, Pluvio J. Coronado Martín, Ignacio Zapardiel, Jesús de la Fuente-Valero
Format: Article
Language:English
Published: MDPI AG 2022-03-01
Series:Vaccines
Subjects:
HPV
vaccine
quadrivalent vaccine
Online Access:https://www.mdpi.com/2076-393X/10/3/387

Internet

https://www.mdpi.com/2076-393X/10/3/387

Similar Items